Steven Post
Concepts (433)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scavenger Receptors, Class A | 13 | 2017 | 38 | 2.690 |
Why?
| Herpesvirus 8, Human | 10 | 2023 | 90 | 1.670 |
Why?
| Macrophages | 7 | 2019 | 405 | 1.620 |
Why?
| Sarcoma, Kaposi | 8 | 2023 | 72 | 1.330 |
Why?
| Tumor Microenvironment | 2 | 2024 | 209 | 0.860 |
Why?
| Signal Transduction | 22 | 2022 | 1753 | 0.860 |
Why?
| Macrophage Colony-Stimulating Factor | 3 | 2011 | 10 | 0.850 |
Why?
| Virus Activation | 6 | 2022 | 30 | 0.840 |
Why?
| Cell Adhesion | 8 | 2016 | 171 | 0.830 |
Why?
| Phospholipases A2 | 3 | 2014 | 19 | 0.830 |
Why?
| Phosphatidylinositol 3-Kinases | 4 | 2014 | 153 | 0.800 |
Why?
| Vulvar Neoplasms | 3 | 2016 | 54 | 0.770 |
Why?
| Monocytes | 2 | 2019 | 156 | 0.700 |
Why?
| Plasma Cells | 2 | 2018 | 238 | 0.700 |
Why?
| Hodgkin Disease | 1 | 2019 | 51 | 0.700 |
Why?
| Antigens, CD | 2 | 2019 | 242 | 0.680 |
Why?
| Peripheral Nerves | 2 | 2015 | 51 | 0.650 |
Why?
| Color | 1 | 2018 | 29 | 0.650 |
Why?
| Automation | 1 | 2018 | 18 | 0.650 |
Why?
| Animals | 42 | 2023 | 14385 | 0.650 |
Why?
| Cyclic AMP | 9 | 2000 | 106 | 0.630 |
Why?
| Immunophenotyping | 1 | 2018 | 117 | 0.630 |
Why?
| Blood Coagulation Tests | 1 | 2017 | 23 | 0.630 |
Why?
| Optics and Photonics | 1 | 2017 | 13 | 0.630 |
Why?
| Carcinoma, Squamous Cell | 3 | 2016 | 384 | 0.630 |
Why?
| Diagnostic Tests, Routine | 1 | 2017 | 31 | 0.610 |
Why?
| Macrophages, Peritoneal | 6 | 2009 | 32 | 0.610 |
Why?
| Immunoglobulins | 1 | 2017 | 89 | 0.600 |
Why?
| Mice | 26 | 2023 | 6413 | 0.590 |
Why?
| Receptors, Purinergic P2 | 5 | 2001 | 37 | 0.580 |
Why?
| Cytoplasm | 2 | 2009 | 108 | 0.570 |
Why?
| Lipoproteins, LDL | 6 | 2011 | 195 | 0.570 |
Why?
| Membrane Proteins | 5 | 2023 | 389 | 0.570 |
Why?
| Breast Neoplasms | 2 | 2024 | 1248 | 0.560 |
Why?
| Gelatinases | 1 | 2016 | 36 | 0.550 |
Why?
| Bone Marrow | 1 | 2018 | 411 | 0.550 |
Why?
| Serine Endopeptidases | 1 | 2016 | 57 | 0.540 |
Why?
| Cell Line | 12 | 2021 | 1153 | 0.540 |
Why?
| Collagen Type I | 1 | 2016 | 97 | 0.530 |
Why?
| Flow Cytometry | 1 | 2018 | 546 | 0.520 |
Why?
| Klebsiella Infections | 1 | 2014 | 12 | 0.510 |
Why?
| Interleukin-6 | 1 | 2016 | 315 | 0.510 |
Why?
| Klebsiella pneumoniae | 1 | 2014 | 23 | 0.510 |
Why?
| Pneumonia, Bacterial | 1 | 2014 | 26 | 0.510 |
Why?
| Membrane Microdomains | 1 | 2014 | 15 | 0.500 |
Why?
| Sepsis | 2 | 2014 | 251 | 0.500 |
Why?
| Thrombocytopenia | 1 | 2014 | 99 | 0.480 |
Why?
| Humans | 43 | 2024 | 54246 | 0.450 |
Why?
| Hemorrhage | 1 | 2014 | 208 | 0.450 |
Why?
| Myocytes, Cardiac | 1 | 2013 | 137 | 0.430 |
Why?
| Heterotrimeric GTP-Binding Proteins | 2 | 2002 | 4 | 0.420 |
Why?
| Neoplasm Recurrence, Local | 2 | 2015 | 644 | 0.420 |
Why?
| Receptors, Scavenger | 6 | 2017 | 28 | 0.410 |
Why?
| Cell Membrane | 4 | 2009 | 278 | 0.400 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 99 | 0.390 |
Why?
| Adenosine Triphosphate | 4 | 2001 | 242 | 0.370 |
Why?
| Receptors, Immunologic | 4 | 2017 | 37 | 0.360 |
Why?
| Transcription Factors | 1 | 2013 | 622 | 0.350 |
Why?
| Receptors, Adrenergic, beta | 4 | 1999 | 41 | 0.350 |
Why?
| Cells, Cultured | 9 | 2020 | 1737 | 0.340 |
Why?
| Antiviral Agents | 2 | 2021 | 188 | 0.340 |
Why?
| GTP-Binding Proteins | 8 | 2000 | 94 | 0.320 |
Why?
| Epithelial Cells | 2 | 2001 | 255 | 0.320 |
Why?
| Enzyme Activation | 5 | 2014 | 329 | 0.320 |
Why?
| rac GTP-Binding Proteins | 1 | 2007 | 6 | 0.320 |
Why?
| Arachidonate 15-Lipoxygenase | 1 | 2007 | 17 | 0.310 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2007 | 11 | 0.310 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2007 | 17 | 0.310 |
Why?
| Receptors, Transferrin | 2 | 2004 | 17 | 0.310 |
Why?
| src-Family Kinases | 1 | 2006 | 54 | 0.290 |
Why?
| Immunohistochemistry | 4 | 2021 | 1089 | 0.290 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 206 | 0.290 |
Why?
| Partial Thromboplastin Time | 2 | 2017 | 12 | 0.270 |
Why?
| Prothrombin Time | 2 | 2017 | 19 | 0.270 |
Why?
| Stromal Cells | 2 | 2016 | 79 | 0.270 |
Why?
| Protein Isoforms | 3 | 2019 | 124 | 0.260 |
Why?
| Female | 14 | 2024 | 28418 | 0.250 |
Why?
| Pertussis Toxin | 2 | 2002 | 9 | 0.250 |
Why?
| Histamine | 2 | 2023 | 28 | 0.240 |
Why?
| Oncogenic Viruses | 2 | 2021 | 17 | 0.240 |
Why?
| Lymph Nodes | 2 | 2016 | 284 | 0.230 |
Why?
| Echinomycin | 1 | 2023 | 7 | 0.230 |
Why?
| Biopsy | 2 | 2016 | 692 | 0.230 |
Why?
| Receptors, Gastrointestinal Hormone | 2 | 1993 | 3 | 0.230 |
Why?
| Retrospective Studies | 5 | 2019 | 6432 | 0.230 |
Why?
| Glucagon | 2 | 1993 | 34 | 0.230 |
Why?
| Coinfection | 2 | 2020 | 34 | 0.230 |
Why?
| Ligands | 5 | 2017 | 230 | 0.230 |
Why?
| Focal Adhesions | 1 | 2002 | 12 | 0.220 |
Why?
| Oncolytic Virotherapy | 1 | 2022 | 18 | 0.220 |
Why?
| Mice, Knockout | 5 | 2014 | 926 | 0.220 |
Why?
| Proteoglycans | 1 | 2023 | 96 | 0.220 |
Why?
| Herpesviridae | 1 | 2022 | 19 | 0.220 |
Why?
| Mice, Inbred C57BL | 6 | 2016 | 1999 | 0.210 |
Why?
| Lung Neoplasms | 2 | 2021 | 642 | 0.210 |
Why?
| Protein Binding | 4 | 2014 | 736 | 0.210 |
Why?
| Dogs | 8 | 2001 | 217 | 0.210 |
Why?
| von Willebrand Factor | 2 | 2019 | 53 | 0.210 |
Why?
| Epstein-Barr Virus Infections | 1 | 2022 | 34 | 0.210 |
Why?
| Protein Transport | 3 | 2014 | 195 | 0.200 |
Why?
| Virulence Factors, Bordetella | 2 | 2000 | 8 | 0.200 |
Why?
| Eukaryotic Initiation Factor-4G | 1 | 2021 | 4 | 0.200 |
Why?
| Lipoproteins, VLDL | 1 | 2000 | 16 | 0.200 |
Why?
| Sphingolipids | 1 | 2020 | 14 | 0.190 |
Why?
| Ceramides | 1 | 2020 | 32 | 0.190 |
Why?
| Virus Latency | 4 | 2023 | 46 | 0.190 |
Why?
| Lymphoma, Primary Effusion | 1 | 2020 | 18 | 0.190 |
Why?
| Neoplasm Invasiveness | 3 | 2016 | 295 | 0.190 |
Why?
| Antigens, Bacterial | 1 | 2020 | 63 | 0.190 |
Why?
| Cell Line, Tumor | 6 | 2022 | 1550 | 0.190 |
Why?
| Cell Survival | 3 | 2021 | 657 | 0.180 |
Why?
| Gene Regulatory Networks | 1 | 2021 | 124 | 0.180 |
Why?
| ABO Blood-Group System | 1 | 2019 | 14 | 0.180 |
Why?
| Mouth | 1 | 2020 | 35 | 0.180 |
Why?
| Carcinoma, Hepatocellular | 1 | 2022 | 203 | 0.180 |
Why?
| Blood Coagulation | 2 | 2017 | 69 | 0.180 |
Why?
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 6 | 0.180 |
Why?
| Drosophila Proteins | 1 | 2019 | 17 | 0.180 |
Why?
| Cell Proliferation | 3 | 2021 | 1096 | 0.180 |
Why?
| Phenotype | 2 | 2019 | 820 | 0.180 |
Why?
| Mice, Transgenic | 3 | 2013 | 656 | 0.180 |
Why?
| Calcium Channels | 1 | 2019 | 59 | 0.170 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 40 | 0.170 |
Why?
| Recombinant Proteins | 3 | 2016 | 569 | 0.170 |
Why?
| Receptors, LDL | 3 | 2004 | 70 | 0.170 |
Why?
| Middle Aged | 8 | 2020 | 13070 | 0.170 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 164 | 0.170 |
Why?
| Mycobacterium tuberculosis | 1 | 2020 | 212 | 0.170 |
Why?
| Neoplasm Staging | 3 | 2016 | 806 | 0.170 |
Why?
| Liver Neoplasms | 1 | 2022 | 352 | 0.160 |
Why?
| HIV Infections | 2 | 2020 | 394 | 0.160 |
Why?
| Pulmonary Embolism | 1 | 2019 | 106 | 0.160 |
Why?
| Glycoproteins | 2 | 2012 | 132 | 0.160 |
Why?
| Male | 12 | 2020 | 27312 | 0.160 |
Why?
| Host-Pathogen Interactions | 1 | 2019 | 143 | 0.160 |
Why?
| Myocardium | 3 | 1999 | 441 | 0.150 |
Why?
| Up-Regulation | 2 | 2011 | 508 | 0.150 |
Why?
| Odds Ratio | 2 | 2015 | 604 | 0.150 |
Why?
| Amino Acid Sequence | 4 | 2009 | 767 | 0.140 |
Why?
| Cell Transformation, Neoplastic | 3 | 2023 | 200 | 0.140 |
Why?
| Molecular Sequence Data | 4 | 2009 | 980 | 0.140 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 866 | 0.140 |
Why?
| Integrins | 1 | 2016 | 36 | 0.140 |
Why?
| Bacterial Proteins | 1 | 2020 | 454 | 0.140 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 1996 | 17 | 0.140 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2016 | 53 | 0.140 |
Why?
| Receptors, Cell Surface | 3 | 2004 | 130 | 0.140 |
Why?
| Heart | 1 | 1999 | 360 | 0.140 |
Why?
| Endopeptidases | 1 | 2016 | 75 | 0.140 |
Why?
| Antiporters | 1 | 2015 | 19 | 0.140 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 56 | 0.140 |
Why?
| Anion Exchange Protein 1, Erythrocyte | 1 | 2015 | 15 | 0.130 |
Why?
| Logistic Models | 2 | 2015 | 990 | 0.130 |
Why?
| S100 Proteins | 1 | 2015 | 41 | 0.130 |
Why?
| Breast | 1 | 2016 | 92 | 0.130 |
Why?
| Fibroma | 1 | 2015 | 41 | 0.130 |
Why?
| Virus Replication | 3 | 2020 | 143 | 0.130 |
Why?
| Arachidonic Acid | 4 | 1999 | 39 | 0.130 |
Why?
| Lymphoma | 1 | 1996 | 72 | 0.130 |
Why?
| Endosonography | 1 | 2015 | 96 | 0.130 |
Why?
| Calreticulin | 2 | 2004 | 12 | 0.120 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 17 | 0.120 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2014 | 53 | 0.120 |
Why?
| Cholesterol | 1 | 2014 | 155 | 0.120 |
Why?
| Heart Failure | 2 | 1999 | 541 | 0.120 |
Why?
| Multivariate Analysis | 1 | 2015 | 643 | 0.120 |
Why?
| Aged, 80 and over | 3 | 2016 | 3429 | 0.120 |
Why?
| Guanine Nucleotides | 1 | 1992 | 3 | 0.110 |
Why?
| Magnesium | 1 | 1992 | 42 | 0.110 |
Why?
| Transfection | 3 | 2009 | 399 | 0.110 |
Why?
| Structure-Activity Relationship | 2 | 2009 | 423 | 0.110 |
Why?
| Paraproteinemias | 1 | 2012 | 80 | 0.110 |
Why?
| Young Adult | 3 | 2020 | 4308 | 0.110 |
Why?
| Receptors, Histamine | 2 | 2023 | 7 | 0.100 |
Why?
| Receptors, Purinergic P2Y2 | 3 | 2001 | 9 | 0.100 |
Why?
| Aged | 5 | 2020 | 10041 | 0.100 |
Why?
| Blood Platelets | 1 | 2014 | 269 | 0.100 |
Why?
| Blotting, Western | 2 | 2003 | 683 | 0.100 |
Why?
| Gene Expression Regulation | 2 | 2019 | 1062 | 0.100 |
Why?
| Uridine Triphosphate | 4 | 1999 | 13 | 0.100 |
Why?
| Herpesviridae Infections | 2 | 2021 | 46 | 0.090 |
Why?
| Adult | 5 | 2020 | 14182 | 0.090 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2021 | 219 | 0.090 |
Why?
| Receptors, Purinergic P2Y1 | 2 | 2001 | 6 | 0.090 |
Why?
| Immunologic Factors | 1 | 2011 | 130 | 0.090 |
Why?
| Amino Acid Motifs | 1 | 2009 | 57 | 0.090 |
Why?
| Kidney | 5 | 1999 | 820 | 0.090 |
Why?
| Risk Factors | 2 | 2015 | 3930 | 0.090 |
Why?
| Liver | 2 | 1993 | 1225 | 0.090 |
Why?
| Disease Models, Animal | 3 | 2022 | 1639 | 0.090 |
Why?
| Models, Biological | 3 | 2007 | 823 | 0.090 |
Why?
| Scavenger Receptors, Class B | 2 | 2006 | 10 | 0.090 |
Why?
| Protein Structure, Tertiary | 3 | 2006 | 289 | 0.090 |
Why?
| Protein Biosynthesis | 1 | 2011 | 273 | 0.090 |
Why?
| Tumor Cells, Cultured | 3 | 2020 | 477 | 0.090 |
Why?
| Neoplasms | 1 | 2019 | 1315 | 0.080 |
Why?
| RNA, Messenger | 2 | 2011 | 1202 | 0.080 |
Why?
| Phosphorylation | 2 | 2006 | 614 | 0.080 |
Why?
| Group VI Phospholipases A2 | 1 | 2007 | 5 | 0.080 |
Why?
| Endothelial Cells | 2 | 2020 | 294 | 0.080 |
Why?
| Treatment Outcome | 2 | 2015 | 5604 | 0.080 |
Why?
| Indomethacin | 2 | 1998 | 40 | 0.080 |
Why?
| Time Factors | 3 | 2015 | 3212 | 0.080 |
Why?
| Cyclooxygenase Inhibitors | 2 | 1998 | 44 | 0.080 |
Why?
| Serum Albumin, Bovine | 1 | 2006 | 25 | 0.070 |
Why?
| Cell Shape | 1 | 2006 | 23 | 0.070 |
Why?
| Malondialdehyde | 1 | 2006 | 63 | 0.070 |
Why?
| DNA, Complementary | 2 | 2004 | 145 | 0.070 |
Why?
| Subcellular Fractions | 1 | 2006 | 43 | 0.070 |
Why?
| Lung | 2 | 2020 | 507 | 0.070 |
Why?
| Femur | 1 | 2006 | 144 | 0.070 |
Why?
| Disease Progression | 2 | 2021 | 913 | 0.070 |
Why?
| Terminology as Topic | 2 | 2017 | 72 | 0.070 |
Why?
| Chi-Square Distribution | 2 | 2016 | 318 | 0.070 |
Why?
| Phosphoproteins | 1 | 2005 | 116 | 0.070 |
Why?
| Lipid Metabolism | 1 | 2006 | 194 | 0.060 |
Why?
| Muscle, Smooth, Vascular | 1 | 2005 | 140 | 0.060 |
Why?
| Hepatocytes | 1 | 2006 | 214 | 0.060 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2005 | 140 | 0.060 |
Why?
| Cell Adhesion Molecules | 1 | 2004 | 87 | 0.060 |
Why?
| Receptors, Lipoprotein | 1 | 2003 | 8 | 0.060 |
Why?
| Antigen-Presenting Cells | 1 | 2003 | 25 | 0.060 |
Why?
| Amidohydrolases | 1 | 2003 | 7 | 0.060 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2003 | 4 | 0.060 |
Why?
| Brefeldin A | 1 | 2003 | 19 | 0.060 |
Why?
| Cell Differentiation | 1 | 2006 | 720 | 0.060 |
Why?
| Cations | 1 | 2003 | 15 | 0.060 |
Why?
| Tunicamycin | 1 | 2003 | 17 | 0.060 |
Why?
| Biotinylation | 1 | 2003 | 23 | 0.060 |
Why?
| Tetracycline | 1 | 2003 | 21 | 0.060 |
Why?
| Glycoside Hydrolases | 1 | 2003 | 27 | 0.060 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2023 | 18 | 0.060 |
Why?
| Osteoclasts | 1 | 2006 | 469 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 124 | 0.060 |
Why?
| Peptides | 2 | 2004 | 276 | 0.060 |
Why?
| Receptors, Glucagon | 2 | 1993 | 9 | 0.060 |
Why?
| Chondroitin Sulfate Proteoglycans | 1 | 2023 | 21 | 0.060 |
Why?
| Receptors, Interleukin-1 | 1 | 2022 | 20 | 0.060 |
Why?
| Muscle Proteins | 1 | 2005 | 307 | 0.060 |
Why?
| Vesiculovirus | 1 | 2022 | 5 | 0.060 |
Why?
| Biopolymers | 1 | 2002 | 14 | 0.060 |
Why?
| Inflammation | 1 | 2007 | 674 | 0.060 |
Why?
| Genetic Vectors | 1 | 2003 | 139 | 0.060 |
Why?
| Antigens, Neoplasm | 1 | 2003 | 170 | 0.060 |
Why?
| Adaptive Immunity | 1 | 2022 | 39 | 0.050 |
Why?
| Rabbits | 2 | 2000 | 425 | 0.050 |
Why?
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2023 | 46 | 0.050 |
Why?
| Phospholipases A | 2 | 1999 | 15 | 0.050 |
Why?
| Endoplasmic Reticulum | 1 | 2003 | 123 | 0.050 |
Why?
| Microscopy, Fluorescence | 1 | 2003 | 198 | 0.050 |
Why?
| Isoproterenol | 3 | 1999 | 52 | 0.050 |
Why?
| Adenosine Monophosphate | 1 | 2022 | 15 | 0.050 |
Why?
| Alanine | 1 | 2022 | 44 | 0.050 |
Why?
| Actins | 1 | 2002 | 132 | 0.050 |
Why?
| Endocytosis | 2 | 2017 | 60 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2022 | 38 | 0.050 |
Why?
| Golgi Apparatus | 1 | 2003 | 120 | 0.050 |
Why?
| Cell Cycle | 1 | 2023 | 275 | 0.050 |
Why?
| RNA, Viral | 1 | 2022 | 141 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 673 | 0.050 |
Why?
| Protein Kinase C | 2 | 2005 | 65 | 0.050 |
Why?
| Benzamidines | 1 | 2021 | 6 | 0.050 |
Why?
| Kidney Tubules, Collecting | 1 | 2001 | 11 | 0.050 |
Why?
| Azithromycin | 1 | 2021 | 42 | 0.050 |
Why?
| Kidney Tubules, Distal | 1 | 2001 | 17 | 0.050 |
Why?
| Nucleotides | 1 | 2001 | 23 | 0.050 |
Why?
| Guanidines | 1 | 2021 | 36 | 0.050 |
Why?
| Wasp Venoms | 1 | 2000 | 1 | 0.050 |
Why?
| Cholesterol Esters | 1 | 2000 | 4 | 0.050 |
Why?
| Androstadienes | 1 | 2000 | 9 | 0.050 |
Why?
| Amino Acids | 1 | 2003 | 369 | 0.050 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2000 | 3 | 0.050 |
Why?
| Iodine Radioisotopes | 1 | 2000 | 43 | 0.050 |
Why?
| Mice, Inbred NOD | 1 | 2020 | 99 | 0.050 |
Why?
| Promoter Regions, Genetic | 1 | 2003 | 520 | 0.050 |
Why?
| Biological Transport, Active | 1 | 2000 | 35 | 0.050 |
Why?
| Mice, Inbred Strains | 1 | 2000 | 198 | 0.050 |
Why?
| Mice, SCID | 1 | 2020 | 196 | 0.050 |
Why?
| Gene Expression Regulation, Viral | 1 | 2020 | 50 | 0.050 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2000 | 122 | 0.050 |
Why?
| Acetylation | 1 | 2000 | 99 | 0.050 |
Why?
| Dinoprostone | 2 | 1999 | 55 | 0.050 |
Why?
| Tissue Array Analysis | 1 | 2019 | 50 | 0.050 |
Why?
| Rats, Sprague-Dawley | 3 | 2005 | 1663 | 0.050 |
Why?
| Paraffin Embedding | 1 | 2019 | 56 | 0.050 |
Why?
| High-Throughput Screening Assays | 1 | 2019 | 37 | 0.040 |
Why?
| Viral Proteins | 1 | 2021 | 158 | 0.040 |
Why?
| Drosophila melanogaster | 1 | 2019 | 24 | 0.040 |
Why?
| HIV | 1 | 2019 | 26 | 0.040 |
Why?
| Tumor Escape | 1 | 2019 | 21 | 0.040 |
Why?
| Virulence Factors | 1 | 2020 | 92 | 0.040 |
Why?
| Glycosylation | 1 | 2019 | 112 | 0.040 |
Why?
| Calcium-Transporting ATPases | 1 | 1999 | 11 | 0.040 |
Why?
| Sarcoplasmic Reticulum | 1 | 1999 | 22 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2020 | 199 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2019 | 125 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2019 | 158 | 0.040 |
Why?
| Cholera Toxin | 2 | 1995 | 16 | 0.040 |
Why?
| Calcium-Binding Proteins | 1 | 1999 | 61 | 0.040 |
Why?
| Thionucleotides | 1 | 1998 | 9 | 0.040 |
Why?
| Autocrine Communication | 1 | 1998 | 10 | 0.040 |
Why?
| Suramin | 1 | 1998 | 14 | 0.040 |
Why?
| Interleukin-1beta | 1 | 2019 | 92 | 0.040 |
Why?
| Prostaglandins | 1 | 1998 | 19 | 0.040 |
Why?
| Paracrine Communication | 1 | 1998 | 12 | 0.040 |
Why?
| HEK293 Cells | 1 | 2019 | 245 | 0.040 |
Why?
| Myocardial Contraction | 1 | 1999 | 116 | 0.040 |
Why?
| Neoplasm Metastasis | 1 | 2019 | 252 | 0.040 |
Why?
| Receptors, Adrenergic, alpha-1 | 1 | 1998 | 12 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2023 | 562 | 0.040 |
Why?
| Multiple Myeloma | 1 | 2012 | 3035 | 0.040 |
Why?
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 15 | 0.040 |
Why?
| Isoenzymes | 1 | 1998 | 177 | 0.040 |
Why?
| Phagocytosis | 1 | 2017 | 51 | 0.040 |
Why?
| Rats | 3 | 2005 | 3415 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 579 | 0.040 |
Why?
| Vimentin | 1 | 2016 | 33 | 0.040 |
Why?
| Receptors, G-Protein-Coupled | 1 | 1996 | 55 | 0.040 |
Why?
| Purinergic P1 Receptor Agonists | 1 | 1996 | 2 | 0.040 |
Why?
| Phospholipases | 1 | 1996 | 3 | 0.040 |
Why?
| Purinergic P2 Receptor Agonists | 1 | 1996 | 4 | 0.040 |
Why?
| Radioligand Assay | 1 | 1996 | 49 | 0.030 |
Why?
| Staphylococcus aureus | 1 | 2020 | 361 | 0.030 |
Why?
| Cadherins | 1 | 2016 | 72 | 0.030 |
Why?
| Cytochalasin B | 1 | 1995 | 2 | 0.030 |
Why?
| MicroRNAs | 1 | 2020 | 386 | 0.030 |
Why?
| beta Catenin | 1 | 2016 | 102 | 0.030 |
Why?
| Algorithms | 1 | 2019 | 697 | 0.030 |
Why?
| Colchicine | 1 | 1995 | 35 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2020 | 1138 | 0.030 |
Why?
| Cerebral Cortex | 1 | 1996 | 234 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2015 | 131 | 0.030 |
Why?
| Cohort Studies | 1 | 2019 | 1543 | 0.030 |
Why?
| Biopsy, Fine-Needle | 1 | 2015 | 116 | 0.030 |
Why?
| Neoplasm, Residual | 1 | 2015 | 166 | 0.030 |
Why?
| Lymphatic Metastasis | 1 | 2015 | 256 | 0.030 |
Why?
| Macrophage-1 Antigen | 1 | 2014 | 8 | 0.030 |
Why?
| Apoptosis | 1 | 2020 | 1300 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2014 | 49 | 0.030 |
Why?
| Ligation | 1 | 2014 | 64 | 0.030 |
Why?
| Interleukin-4 | 1 | 2014 | 48 | 0.030 |
Why?
| Cecum | 1 | 2014 | 72 | 0.030 |
Why?
| Cell Communication | 1 | 2014 | 72 | 0.030 |
Why?
| Hemostasis | 1 | 2014 | 56 | 0.030 |
Why?
| Heart Ventricles | 1 | 1995 | 271 | 0.030 |
Why?
| Guanosine Diphosphate | 1 | 1992 | 8 | 0.030 |
Why?
| Saponins | 1 | 1992 | 7 | 0.030 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1992 | 13 | 0.030 |
Why?
| Guanosine Triphosphate | 1 | 1992 | 23 | 0.030 |
Why?
| Cell Membrane Permeability | 1 | 1992 | 28 | 0.030 |
Why?
| Binding, Competitive | 1 | 1993 | 113 | 0.030 |
Why?
| Fibrinogen | 1 | 2012 | 37 | 0.030 |
Why?
| Neutrophils | 1 | 2014 | 154 | 0.030 |
Why?
| Neurons | 1 | 1996 | 486 | 0.030 |
Why?
| Receptors, Somatostatin | 1 | 1992 | 2 | 0.030 |
Why?
| Receptors, Neurotransmitter | 1 | 1992 | 15 | 0.030 |
Why?
| Reference Values | 1 | 2012 | 354 | 0.030 |
Why?
| Temperature | 1 | 1992 | 177 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 434 | 0.030 |
Why?
| Kinetics | 1 | 1992 | 692 | 0.020 |
Why?
| Thrombosis | 1 | 2014 | 243 | 0.020 |
Why?
| Prognosis | 1 | 2015 | 2118 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2015 | 2387 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2012 | 1084 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2004 | 1476 | 0.020 |
Why?
| Lipoproteins, HDL | 1 | 2006 | 21 | 0.020 |
Why?
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2005 | 2 | 0.020 |
Why?
| Myosin-Light-Chain Phosphatase | 1 | 2005 | 2 | 0.020 |
Why?
| rhoA GTP-Binding Protein | 1 | 2005 | 8 | 0.020 |
Why?
| Maleimides | 1 | 2005 | 9 | 0.020 |
Why?
| Tissue Distribution | 1 | 2006 | 178 | 0.020 |
Why?
| rho-Associated Kinases | 1 | 2005 | 20 | 0.020 |
Why?
| United States | 1 | 2017 | 5200 | 0.020 |
Why?
| Amides | 1 | 2005 | 43 | 0.020 |
Why?
| Immunoblotting | 1 | 2005 | 134 | 0.020 |
Why?
| Mesenteric Arteries | 1 | 2005 | 45 | 0.020 |
Why?
| RANK Ligand | 1 | 2006 | 183 | 0.020 |
Why?
| Muscle Contraction | 1 | 2005 | 109 | 0.020 |
Why?
| Sex Characteristics | 1 | 2006 | 214 | 0.020 |
Why?
| Scavenger Receptors, Class F | 1 | 2004 | 3 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 151 | 0.020 |
Why?
| Aorta | 1 | 2005 | 177 | 0.020 |
Why?
| CHO Cells | 1 | 2004 | 123 | 0.020 |
Why?
| Pyridines | 1 | 2005 | 137 | 0.020 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2004 | 61 | 0.020 |
Why?
| Cricetinae | 1 | 2004 | 209 | 0.020 |
Why?
| Polysaccharides | 1 | 2004 | 57 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2004 | 64 | 0.020 |
Why?
| Bone Density | 1 | 2006 | 416 | 0.020 |
Why?
| Body Weight | 1 | 2006 | 578 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 2004 | 116 | 0.020 |
Why?
| Dendritic Cells | 1 | 2004 | 142 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 2004 | 233 | 0.010 |
Why?
| Polymerase Chain Reaction | 2 | 1998 | 531 | 0.010 |
Why?
| Insulin | 1 | 2006 | 510 | 0.010 |
Why?
| Body Mass Index | 1 | 2006 | 712 | 0.010 |
Why?
| Glucose | 1 | 2005 | 366 | 0.010 |
Why?
| Base Sequence | 2 | 1996 | 719 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2005 | 446 | 0.010 |
Why?
| Indoles | 1 | 2005 | 289 | 0.010 |
Why?
| Phospholipase D | 1 | 1999 | 5 | 0.010 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 39 | 0.010 |
Why?
| Transduction, Genetic | 1 | 1999 | 50 | 0.010 |
Why?
| Papillary Muscles | 1 | 1999 | 18 | 0.010 |
Why?
| Feedback | 1 | 1999 | 59 | 0.010 |
Why?
| Epinephrine | 1 | 1999 | 97 | 0.010 |
Why?
| Diglycerides | 1 | 1998 | 12 | 0.010 |
Why?
| Phosphatidylinositols | 1 | 1998 | 25 | 0.010 |
Why?
| Arachidonic Acids | 1 | 1998 | 26 | 0.010 |
Why?
| Potassium Channels | 1 | 1998 | 41 | 0.010 |
Why?
| Inositol 1,4,5-Trisphosphate | 1 | 1996 | 12 | 0.010 |
Why?
| Receptors, Lysophosphatidic Acid | 1 | 1996 | 4 | 0.010 |
Why?
| Phosphatidylcholines | 1 | 1996 | 33 | 0.010 |
Why?
| Cell Size | 1 | 1996 | 45 | 0.010 |
Why?
| Embryo, Mammalian | 1 | 1996 | 68 | 0.010 |
Why?
| Lysophospholipids | 1 | 1996 | 34 | 0.010 |
Why?
| Animals, Newborn | 1 | 1998 | 396 | 0.010 |
Why?
| Gene Expression Regulation, Developmental | 1 | 1996 | 151 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1996 | 368 | 0.010 |
Why?
| Cytoskeleton | 1 | 1995 | 50 | 0.010 |
Why?
| Age Factors | 1 | 1996 | 1195 | 0.010 |
Why?
| Digestive System Physiological Phenomena | 1 | 1992 | 3 | 0.010 |
Why?
| Blotting, Southern | 1 | 1992 | 40 | 0.010 |
Why?
| Islets of Langerhans | 1 | 1992 | 23 | 0.010 |
Why?
| Genes | 1 | 1992 | 38 | 0.010 |
Why?
| Blotting, Northern | 1 | 1992 | 108 | 0.010 |
Why?
| Somatostatin | 1 | 1992 | 26 | 0.010 |
Why?
| Cloning, Molecular | 1 | 1992 | 198 | 0.010 |
Why?
| Sequence Alignment | 1 | 1992 | 146 | 0.010 |
Why?
| Gene Expression | 1 | 1992 | 664 | 0.010 |
Why?
| Pregnancy | 1 | 1996 | 2620 | 0.010 |
Why?
| DNA | 1 | 1992 | 581 | 0.000 |
Why?
| Brain | 1 | 1992 | 1387 | 0.000 |
Why?
|
|
Post's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|